by lorenzgerber | Jun 1, 2023 | Events
Florian Schmidt, PhD will be presenting at the upcoming ISMB/ECCB 2023 conference in Lyon. On Thursday, July 27th Florian will describe ImmunoScape’s machine learning capability, which we use to infer antigen specificity. He will present in-vitro validation data,...
by lorenzgerber | May 1, 2023 | Events
Our team is headed to #bio2023 in Boston June 5-8! Our CEO Choon-Peng (Choon) Ng and our Senior Director, Business Development Christopher Alfonso will be on site at the convention this year. If you are interested in meeting with them to learn more about our Deep...
by lorenzgerber | Feb 15, 2023 | News
Ayesha Siddiqui from BioSpectrum Asia spoke with our CEO and Co-Founder Choon-Peng (Choon) Ng about the progress around cancer research in Asia for her recent piece. See what Choon had to say in the full piece linked below....
by lorenzgerber | Jan 20, 2023 | News
Our CEO and co-founder, Choon-Peng (Choon) Ng recently spoke with BioSpectrum Asia about how our unique Deep Immunomics and machine learning platforms can discover and develop novel TCR-based therapeutics against a diverse range of tumor antigens. You can see the full...
by lorenzgerber | Jan 19, 2023 | News
Our CEO and co-founder, Choon-Peng (Choon) Ng recently spoke with BioSpectrum Asia about how our unique Deep Immunomics and machine learning platforms can discover and develop novel TCR-based therapeutics against a diverse range of tumor antigens. You can see the full...
by lorenzgerber | Dec 13, 2022 | Events
Are you attending the 41st Annual JPM Healthcare Conference in San Francisco next month? Our CEO, Choon-Peng Ng, and Dan MacLeod, VP Discovery, will be on-site January 9-10th. We look forward to connecting with industry peers, sharing insights, and discussing...
by lorenzgerber | Oct 15, 2022 | News
Andreas Wilm, Director of Computational Biology and Lorenz Gerber, Associate Director of Software Engineering at ImmunoScape contributed a blog post for Amazon Web Services (AWS) to share how we were able to build an agile drug discovery pipeline with scalable compute...
by lorenzgerber | Oct 1, 2022 | Events
One of our senior scientists in discovery, Juliana Barclay, will be presenting at Society for Immunotherapy of Cancer (SITC) 2022 in Boston this Friday, November 11. Juliana will present on the discovery and development of t-cell receptors for adoptive T-cell therapy...
by lorenzgerber | Oct 1, 2022 | News
ImmunoScape’s CEO Choon-Peng Ng is featured in Endpoints. Endpoints highlights ImmunoScape’s $14M funding round, our use of machine learning to discover TCR-T cell therapies focused on solid tumors, and our progress toward the clinic. You can read the full...
